Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs

Phase 4

Recruiting

• Conditions: First Episode Psychosis

• Registration Number: NCT04005378
• Lead Sponsor: Northwell Health

Brief Summary

Maintaining treatment engagement is critical for first episode psychosis patients to experience gains possible with coordinated specialty care (CSC). This study is designed to identify CSC participants still receiving care but at high risk for disengagement and to intervene to prevent/delay disengagement.

Detailed Description

In Phase 1 of the project, we will confirm a model predicting factors associated with later disengagement from CSC treatment. In Phase 2, we will compare disengagement among high-risk individuals with a CSC Step-down intervention to that with standard CSC care. The Step-down intervention will use web-based telemedicine and a smartphone app, to decrease disengagement likelihood. High-risk participants identified by predictors found in Phase 1 will be offered the intervention.

Study Timeline

• Study First Submitted: 2019-07-01
• Study First Submitted QC: 2019-07-01
• Study First Posted: 2019-07-02
• Study Start: 2020-07-01
• Status Verified: 2023-09
• Last Update Submitted: 2023-09-28
• Last Update Posted: 2023-09-29
• Primary Completion: 2024-04-15
• Study Completion: 2024-05-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

• Enrolled into a CSC program

Exclusion Criteria

• None

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Disengagement rate	Minimum of 6 months	Rate of disengagement from CSC program

Trial Locations

Locations (2)

Henderson Behavioral Health; 🇺🇸 Lauderdale Lakes, Florida, United States

InterAct of Michigan; 🇺🇸 Kalamazoo, Michigan, United States